Danaher (NYSE:DHR) Hits New 1-Year High at $138.99

Danaher Co. (NYSE:DHR)’s share price hit a new 52-week high on Tuesday . The company traded as high as $138.99 and last traded at $137.97, with a volume of 1752500 shares changing hands. The stock had previously closed at $137.52.

A number of equities analysts have recently weighed in on DHR shares. Zacks Investment Research downgraded Danaher from a “buy” rating to a “hold” rating in a report on Tuesday, April 23rd. Deutsche Bank increased their price objective on Danaher to $130.00 and gave the stock a “buy” rating in a report on Tuesday, February 26th. Jefferies Financial Group increased their price objective on Danaher to $140.00 and gave the stock a “buy” rating in a report on Tuesday, February 26th. UBS Group increased their price objective on Danaher from $125.00 to $144.00 and gave the stock a “buy” rating in a report on Tuesday, February 26th. Finally, Needham & Company LLC restated a “buy” rating and issued a $141.00 price objective (up previously from $138.00) on shares of Danaher in a report on Wednesday, April 17th. Three research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. Danaher has an average rating of “Buy” and an average price target of $133.00.

The firm has a market capitalization of $98.46 billion, a P/E ratio of 30.70, a P/E/G ratio of 2.66 and a beta of 0.95. The company has a quick ratio of 1.74, a current ratio of 2.18 and a debt-to-equity ratio of 0.32.

Danaher (NYSE:DHR) last released its quarterly earnings data on Thursday, April 18th. The conglomerate reported $1.07 EPS for the quarter, topping analysts’ consensus estimates of $1.01 by $0.06. Danaher had a return on equity of 11.61% and a net margin of 12.04%. The firm had revenue of $4.88 billion for the quarter, compared to the consensus estimate of $4.80 billion. During the same quarter in the prior year, the company posted $0.99 earnings per share. The firm’s revenue was up 3.9% on a year-over-year basis. As a group, equities research analysts forecast that Danaher Co. will post 4.77 earnings per share for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Friday, July 26th. Shareholders of record on Friday, June 28th will be issued a dividend of $0.17 per share. The ex-dividend date of this dividend is Thursday, June 27th. This represents a $0.68 annualized dividend and a yield of 0.49%. Danaher’s dividend payout ratio (DPR) is presently 15.04%.

In other Danaher news, SVP William King sold 12,950 shares of the stock in a transaction that occurred on Wednesday, May 29th. The stock was sold at an average price of $129.92, for a total transaction of $1,682,464.00. Following the transaction, the senior vice president now owns 29,070 shares in the company, valued at $3,776,774.40. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Alan G. Spoon sold 1,913 shares of the stock in a transaction that occurred on Wednesday, April 24th. The shares were sold at an average price of $129.52, for a total value of $247,771.76. Following the transaction, the director now owns 86,863 shares in the company, valued at approximately $11,250,495.76. The disclosure for this sale can be found here. In the last quarter, insiders have sold 453,448 shares of company stock worth $59,724,640. Corporate insiders own 11.40% of the company’s stock.

A number of hedge funds have recently made changes to their positions in DHR. CX Institutional boosted its position in shares of Danaher by 188.7% in the first quarter. CX Institutional now owns 205 shares of the conglomerate’s stock valued at $27,000 after acquiring an additional 134 shares during the period. Laurel Wealth Advisors LLC bought a new stake in shares of Danaher in the fourth quarter valued at approximately $27,000. Lenox Wealth Management Inc. bought a new stake in shares of Danaher in the first quarter valued at approximately $40,000. Hanson McClain Inc. boosted its position in shares of Danaher by 852.9% in the fourth quarter. Hanson McClain Inc. now owns 324 shares of the conglomerate’s stock valued at $33,000 after acquiring an additional 290 shares during the period. Finally, Executive Wealth Management LLC bought a new stake in shares of Danaher in the fourth quarter valued at approximately $39,000. Institutional investors own 78.93% of the company’s stock.

TRADEMARK VIOLATION NOTICE: This article was originally reported by WKRB News and is the sole property of of WKRB News. If you are reading this article on another publication, it was illegally copied and reposted in violation of U.S. & international trademark & copyright law. The correct version of this article can be accessed at https://www.wkrb13.com/2019/06/13/danaher-nysedhr-hits-new-1-year-high-at-138-99.html.

Danaher Company Profile (NYSE:DHR)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.

Featured Story: Stock Symbol

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.

Danaher (NYSE:DHR) Hits New 1-Year High at $138.99

Danaher Co. (NYSE:DHR)’s share price hit a new 52-week high on Tuesday . The company traded as high as $138.99 and last traded at $137.97, with a volume of 1752500 shares changing hands. The stock had previously closed at $137.52.

A number of equities analysts have recently weighed in on DHR shares. Zacks Investment Research downgraded Danaher from a “buy” rating to a “hold” rating in a report on Tuesday, April 23rd. Deutsche Bank increased their price objective on Danaher to $130.00 and gave the stock a “buy” rating in a report on Tuesday, February 26th. Jefferies Financial Group increased their price objective on Danaher to $140.00 and gave the stock a “buy” rating in a report on Tuesday, February 26th. UBS Group increased their price objective on Danaher from $125.00 to $144.00 and gave the stock a “buy” rating in a report on Tuesday, February 26th. Finally, Needham & Company LLC restated a “buy” rating and issued a $141.00 price objective (up previously from $138.00) on shares of Danaher in a report on Wednesday, April 17th. Three research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. Danaher has an average rating of “Buy” and an average price target of $133.00.

The firm has a market capitalization of $98.46 billion, a P/E ratio of 30.70, a P/E/G ratio of 2.66 and a beta of 0.95. The company has a quick ratio of 1.74, a current ratio of 2.18 and a debt-to-equity ratio of 0.32.

Danaher (NYSE:DHR) last released its quarterly earnings data on Thursday, April 18th. The conglomerate reported $1.07 EPS for the quarter, topping analysts’ consensus estimates of $1.01 by $0.06. Danaher had a return on equity of 11.61% and a net margin of 12.04%. The firm had revenue of $4.88 billion for the quarter, compared to the consensus estimate of $4.80 billion. During the same quarter in the prior year, the company posted $0.99 earnings per share. The firm’s revenue was up 3.9% on a year-over-year basis. As a group, equities research analysts forecast that Danaher Co. will post 4.77 earnings per share for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Friday, July 26th. Shareholders of record on Friday, June 28th will be issued a dividend of $0.17 per share. The ex-dividend date of this dividend is Thursday, June 27th. This represents a $0.68 annualized dividend and a yield of 0.49%. Danaher’s dividend payout ratio (DPR) is presently 15.04%.

In other Danaher news, SVP William King sold 12,950 shares of the stock in a transaction that occurred on Wednesday, May 29th. The stock was sold at an average price of $129.92, for a total transaction of $1,682,464.00. Following the transaction, the senior vice president now owns 29,070 shares in the company, valued at $3,776,774.40. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Alan G. Spoon sold 1,913 shares of the stock in a transaction that occurred on Wednesday, April 24th. The shares were sold at an average price of $129.52, for a total value of $247,771.76. Following the transaction, the director now owns 86,863 shares in the company, valued at approximately $11,250,495.76. The disclosure for this sale can be found here. In the last quarter, insiders have sold 453,448 shares of company stock worth $59,724,640. Corporate insiders own 11.40% of the company’s stock.

A number of hedge funds have recently made changes to their positions in DHR. CX Institutional boosted its position in shares of Danaher by 188.7% in the first quarter. CX Institutional now owns 205 shares of the conglomerate’s stock valued at $27,000 after acquiring an additional 134 shares during the period. Laurel Wealth Advisors LLC bought a new stake in shares of Danaher in the fourth quarter valued at approximately $27,000. Lenox Wealth Management Inc. bought a new stake in shares of Danaher in the first quarter valued at approximately $40,000. Hanson McClain Inc. boosted its position in shares of Danaher by 852.9% in the fourth quarter. Hanson McClain Inc. now owns 324 shares of the conglomerate’s stock valued at $33,000 after acquiring an additional 290 shares during the period. Finally, Executive Wealth Management LLC bought a new stake in shares of Danaher in the fourth quarter valued at approximately $39,000. Institutional investors own 78.93% of the company’s stock.

TRADEMARK VIOLATION NOTICE: This article was originally reported by WKRB News and is the sole property of of WKRB News. If you are reading this article on another publication, it was illegally copied and reposted in violation of U.S. & international trademark & copyright law. The correct version of this article can be accessed at https://www.wkrb13.com/2019/06/13/danaher-nysedhr-hits-new-1-year-high-at-138-99.html.

Danaher Company Profile (NYSE:DHR)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.

Featured Story: Stock Symbol

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.